Your browser doesn't support javascript.
loading
Likelihood of depressive symptoms in US older adults by prescribed opioid potency: National Health and Nutrition Examination Survey 2005-2013.
Brooks, Jessica M; Petersen, Curtis; Kelly, Stephanie M; Reid, Manney C.
Afiliação
  • Brooks JM; Geriatric Research, Education, and Clinical Center, James J. Peters VA Medical Center, Bronx, NY.
  • Petersen C; Quantiative Biomedical Sciences, Geisel School of Medicine, Dartmouth College, Lebanon, NH.
  • Kelly SM; Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, Lebanon, NH.
  • Reid MC; Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, Lebanon, NH.
Int J Geriatr Psychiatry ; 34(10): 1481-1489, 2019 10.
Article em En | MEDLINE | ID: mdl-31134673
ABSTRACT

OBJECTIVES:

To investigate the relationships between depressive symptoms and opioid potency among adults aged 50 years and older reporting use of one or more prescription opioids in the past 30 days. MATERIALS/

DESIGN:

Adjusted multiple linear regression models were conducted with 2005-2013 files from a secondary cross-sectional dataset, the National Health and Nutrition Examination Survey (NHANES). Respondents were community-dwelling, noninstitutionalized adults 50 years or older (n = 1036). Predictor variables included a positive screen for minor depression symptoms (Patient Health Questionnaire [PHQ-9] score greater than or equal to 5 and less than or equal to 9), moderate depression symptoms (PHQ-9 greater than or equal to 10 and less than or equal to 14), and severe depression symptoms (PHQ-9 greater than or equal to 15). Criterion variables included weaker-than-morphine analgesics (eg, codeine and tramadol) and morphine-equivalent opioids (eg, morphine and hydrocodone), which served as the reference category, as well as stronger-than-morphine opioid analgesics (eg, fentanyl and oxycodone).

RESULTS:

Prevalence rates for symptoms of minor depression, moderate depression, and severe depression were n = 236 (22.8%), n = 135 (13.0%), and n = 122 (11.8%), respectively. Severe depression was significantly associated with high-potency opioid use (odds ratio [OR] 2.27; confidence interval [CI], 1.16-4.46). In post hoc tests, severe depression remained significantly associated with high-potency opioid use only among respondents without arthritis (OR 5.80; CI, 1.59-21.13).

CONCLUSIONS:

Compared with older adults without depressive symptoms, older adults with severe depressive symptoms are more likely to be taking high-potency opioid medications. Future prescription opioid medication research should prioritize investigations among older adults with pain-related diagnoses, other than arthritis, reporting preexisting or new symptoms of severe depression.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dor / Prescrições de Medicamentos / Inquéritos Nutricionais / Depressão / Transtorno Depressivo / Analgésicos Opioides Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dor / Prescrições de Medicamentos / Inquéritos Nutricionais / Depressão / Transtorno Depressivo / Analgésicos Opioides Idioma: En Ano de publicação: 2019 Tipo de documento: Article